Literature DB >> 16361000

National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005.

Andrew Tonkin, Philip Barter, James Best, Andrew Boyden, John Furler, Ken Hossack, David Sullivan, Peter Thompson, Margarite Vale, Catherine Cooper, Malia Robinson, Eleanor Clune.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16361000     DOI： 10.1016/j.hlc.2005.10.010

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN： 1443-9506            Impact factor:   2.975


× No keyword cloud information.
  35 in total

1.  Statins down under.

Authors:  Andrea Mant; Jocelyn Lowinger; Wayne Hall; Susan Whicker; Clare Ringland; Helen Stark
Journal:  Br J Clin Pharmacol       Date:  2006-08-02       Impact factor: 4.335

2.  New Zealand cardiovascular guidelines: best practice evidence-based guideline: the assessment and management of cardiovascular risk December 2003.

Authors:  Michael Crooke
Journal:  Clin Biochem Rev       Date:  2007-02

3.  Rationale for recommendations for lipid testing and reporting by Australian pathology laboratories.

Authors:  David R Sullivan; David W Thomas; David P Tognarini
Journal:  Clin Biochem Rev       Date:  2007-05

4.  Recommendations for Lipid Testing and Reporting by Australian Pathology Laboratories: an important development.

Authors:  Graham R D Jones
Journal:  Clin Biochem Rev       Date:  2007-05

5.  Standardisation of reference intervals: an Australasian view.

Authors:  Graham Jones; Antony Barker
Journal:  Clin Biochem Rev       Date:  2007-11

6.  Protocol and baseline data from The Inala Chronic Disease Management Service evaluation study: a health services intervention study for diabetes care.

Authors:  Deborah A Askew; Claire L Jackson; Robert S Ware; Anthony Russell
Journal:  BMC Health Serv Res       Date:  2010-05-24       Impact factor: 2.655

7.  Exercise Training for Heart Failure Patients with and without Systolic Dysfunction: An Evidence-Based Analysis of How Patients Benefit.

Authors:  Neil Smart
Journal:  Cardiol Res Pract       Date:  2010-09-30       Impact factor: 1.866

8.  Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study.

Authors:  Kevin P Mc Namara; Johnson George; Sharleen L O'Reilly; Shane L Jackson; Gregory M Peterson; Helen Howarth; Michael J Bailey; Gregory Duncan; Peta Trinder; Elizabeth Morabito; Jill Finch; Stephen Bunker; Edward Janus; Jon Emery; James A Dunbar
Journal:  BMC Health Serv Res       Date:  2010-09-07       Impact factor: 2.655

9.  Secondary prevention of heart disease--knowledge among cardiologists and omega-3 (omega-3) fatty acid prescribing behaviors in Karachi, Pakistan.

Authors:  Saqib A Gowani; Sana Shoukat; Ather M Taqui; Hashim M Hanif; Wasiq F Rawasia; Zeeshan Qadri; Sajid H Dhakam
Journal:  BMC Cardiovasc Disord       Date:  2009-01-27       Impact factor: 2.298

10.  An electronic clinical decision support tool to assist primary care providers in cardiovascular disease risk management: development and mixed methods evaluation.

Authors:  David P Peiris; Rohina Joshi; Ruth J Webster; Patrick Groenestein; Tim P Usherwood; Emma Heeley; Fiona M Turnbull; Alexandra Lipman; Anushka A Patel
Journal:  J Med Internet Res       Date:  2009-12-17       Impact factor: 5.428
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.